Dr Craig Primack

Digital

What does Hims & Hers aspire to achieve as it enters into new markets? Dr Craig Primack discusses misinformation surrounding obesity and weight loss.

News

argenx's CD122 inhibitor FB102, added to its pipeline through the $2.2bn acquisition of Forte, is moving into phase 3 testing for coeliac disease.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.